Immune Cell Populations in the Endometrium
Launched by JAGIELLONIAN UNIVERSITY · Feb 8, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the role of immune cells in the uterus and how they may affect women's ability to become pregnant and maintain a pregnancy. Researchers want to understand how changes in immune cell populations, particularly natural killer (NK) cells, relate to infertility and recurrent miscarriages in women who haven't been able to find a clear reason for their difficulties. By comparing the immune cells in the blood and uterus of women with these challenges to those in women who have successfully conceived, the study aims to gain insights that could lead to better treatments or diagnostic methods.
To be eligible for this trial, participants must be women aged 18 to 45 who have experienced unexplained infertility and at least two miscarriages. Women who have had a miscarriage, surgery, or certain infections in the last three months, or who have taken antibiotics recently, cannot participate. If you join the study, you can expect to undergo tests that will help researchers better understand the connection between immune cells and fertility issues. This research could provide important information for improving care for women facing similar challenges in the future.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • age 18-45 years
- • idiopathic infertility
- • at least 2 miscarriages
- • other benign gynecological conditions subjected to endometrial sampling
- Exclusion Criteria:
- • miscarriage within last 3 months
- • abdominal/uterine surgery within last 3 months
- • viral/bacterial infection within last 3 months
- • antibiotic therapy within last 3 months
About Jagiellonian University
Jagiellonian University, one of the oldest and most prestigious institutions of higher education in Poland, is a leading sponsor of clinical trials dedicated to advancing medical research and healthcare innovation. With a strong commitment to scientific excellence, the university leverages its extensive resources, multidisciplinary expertise, and collaborative network to conduct rigorous clinical studies that contribute to the development of new therapies and treatment strategies. Jagiellonian University emphasizes ethical research practices and strives to enhance patient outcomes through evidence-based findings, making significant contributions to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Kazimierz Pityński, Prof., PhD
Study Chair
Jagiellonian University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported